Litigation
Jan. 21, 2011
HIV Drug Suit Can Proceed
On Friday, an Oakland federal judge ruled lawsuits accusing Abbott Laboratories of unlawfully raising an anti-HIV drug's prices could proceed, denying most of Abbott's motion for summary judgment.
Daily Journal Staff Writer
SAN FRANCISCO - In 2003, when Abbott Laboratories was considering what to do to maintain a dominant position in the market for HIV drugs, the company dismissed withdrawing one of its drugs from the market as a potential public relations disaster.
The drug, Norvir, is important on its own but also as a "booster" to increase the efficacy of other protease inhibitors, which help HIV patients ...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In